IFP Advisors’s Aptose Biosciences, Inc. APTO Stock Holding History

IFP Advisors’s Portfolio APTO Stock Details APTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-2	Closed	-$4K	–	4068
2018 Q2	$4K	Buy	+2	New	+$3.19K	﹤0.01%	3415

Other funds holding APTO

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

PFGIA

Patriot Financial Group Insurance Agency Westborough, Massachusetts $974M AUM 29.77% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return

Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

IFP Advisors's APTO Position: Q3 2018 in Review

IFP Advisors sold out of Aptose Biosciences, Inc. (APTO) in Q3 2018, closing a stake of 2 shares — an estimated $4K sold.

IFP Advisors first reported a position in APTO in Q2 2018 and held it in 1 quarter. The position peaked at $4K in Q2 2018. 17 funds tracked by Wall St. Rank hold APTO as of Q3 2018.

IFP Advisors reported no remaining Aptose Biosciences, Inc. position as of Q3 2018 after selling out during the quarter.
IFP Advisors sold 2 Aptose Biosciences, Inc. shares in Q3 2018, an estimated $4K.
IFP Advisors first reported a position in Aptose Biosciences, Inc. in Q2 2018 and held it in 1 quarter.
IFP Advisors's Aptose Biosciences, Inc. position peaked at $4K in Q2 2018.
17 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q3 2018.

Based on IFP Advisors's 13F filing for Q3 2018, filed 25 Oct 2018.